Page last updated: 2024-08-24

trovafloxacin and Breast Neoplasms

trovafloxacin has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, L; Han, S; Liu, H; Liu, S; Ma, J; Pan, X; Shen, H; Wang, H; Wang, S; Yuan, Q; Zhang, F	1

Other Studies

1 other study(ies) available for trovafloxacin and Breast Neoplasms

Article	Year
Activation of Prodrugs by NIR-Triggered Release of Exogenous Enzymes for Locoregional Chemo-photothermal Therapy. Angewandte Chemie (International ed. in English), 2019, 06-03, Volume: 58, Issue:23 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Combined Modality Therapy; Drug Delivery Systems; Drug Liberation; Female; Glucosinolates; Glycoside Hydrolases; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Isothiocyanates; Metal Nanoparticles; Mice; Photochemotherapy; Phototherapy; Prodrugs; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019

Article

Year

Activation of Prodrugs by NIR-Triggered Release of Exogenous Enzymes for Locoregional Chemo-photothermal Therapy.

Angewandte Chemie (International ed. in English), 2019, 06-03, Volume: 58, Issue:23

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Combined Modality Therapy; Drug Delivery Systems; Drug Liberation; Female; Glucosinolates; Glycoside Hydrolases; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Isothiocyanates; Metal Nanoparticles; Mice; Photochemotherapy; Phototherapy; Prodrugs; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019